Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KETABRAIN: Ketamine vs Sufentanil in TBI
NCT02232347Phase 2Unknown
- Start
- Oct 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in traumatic brain injury (TBI) (2 arms). Primary endpoint: Brain Glutamate Concentrations. Status: unknown.
02
Drugs
ketamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02232347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02232347.